Daily Close: Treasury relief stops the slide, but the reset is not over

Target, Lowe's and Estee Lauder supplied pockets of earnings support, while Moderna surged after positive late-stage melanoma-vaccine results with Merck. Those company-specific moves improved breadth in parts of consumer and healthcare, but they were secondary to the bond-market story.

What this means: earnings can still create strong single-stock opportunities, but the index-level environment remains unusually sensitive to rates. For swing traders, strong reports matter more when the broader tape is not simultaneously tightening financial conditions through rising yields.

The U.S. Treasury said it would increase purchases of longer-dated government debt, including doubling buybacks for bonds maturing in 10 years or more to at least $4 billion per operation from $2 billion beginning September 9. Long yields fell after the announcement; the 10-year Treasury yield moved to about 4.64% and the 30-year to about 5.18%. That mattered because the prior session's equity weakness had been tied directly to a sharp rise in long-term borrowing costs.

What this means: falling yields loosen the immediate valuation pressure on growth stocks, but one policy announcement does not erase the underlying concerns around inflation, deficits and Fed credibility. The key follow-through signal is whether long yields stay contained rather than simply bounce back after today's relief move.

Healthcare and biotech supplied clear relative strength, led by Moderna and Merck, while consumer names such as Estee Lauder also rallied on earnings. Small caps outperformed the major large-cap indexes, with the Russell 2000 up 0.5%, a useful sign that the rebound was not limited to the largest technology companies. At the same time, parts of technology remained mixed, including weakness in Broadcom. Compared with the previous session's semiconductor-led pressure, today's tape showed better breadth but not a clean return to concentrated growth leadership. Over the recent week, that shift argues for watching rotation rather than assuming the prior leadership regime has immediately resumed.

The Nasdaq's 0.2% gain was enough to stop the recent slide, but it still trails the S&P 500 for the week and remains 1.5% lower over the current week. The important change from the previous session was the drop in long yields, which reduces one of the strongest near-term headwinds for long-duration growth valuations. Recent sessions have shown that mega-cap and AI-linked names remain highly sensitive to the direction of the bond market. A durable improvement would require both calmer yields and renewed upside participation from leading growth names rather than index stabilization alone.

Base case: today's move is a stabilization attempt after a three-session decline, with the primary uptrend intact but short-term momentum still damaged. The market can consolidate constructively if long yields remain below this week's stress levels.

Upside-risk case: Treasury-market relief persists, breadth continues to improve, and growth leadership re-engages. That would increase the odds that the recent decline was a normal reset rather than the start of a deeper correction.

Downside-risk case: long yields resume their climb, technology leadership weakens again, and today's bounce fails quickly. That would reinforce the idea that tighter financial conditions are becoming a more persistent equity headwind.

What would change the thesis: a decisive index breakout accompanied by improving breadth and stable-to-lower long yields would strengthen the bullish case; renewed yield spikes and another loss of recent index support would shift the near-term posture more defensive.